FATE THERAPEUTICS INC. - COMMON STOCK
3.9000
17-May-24 15:59:59
15 minutes delayed
Stocks
-0.2400
-5.80%
Today's range
3.8700 - 4.1800
ISIN
N/A
Source
NASDAQ
-
05 Jan 2023 17:00:00 By Nasdaq GlobeNewswire
-
13 Dec 2022 08:00:02 By Nasdaq GlobeNewswire
-
10 Dec 2022 14:46:50 By Nasdaq GlobeNewswire
-
10 Dec 2022 10:00:00 By Nasdaq GlobeNewswire
-
07 Nov 2022 08:00:02 By Nasdaq GlobeNewswire
-
Fate Therapeutics to Present at Upcoming Investor Conferences
04 Nov 2022 16:01:00 By Nasdaq GlobeNewswire
-
Fate Therapeutics Reports Third Quarter 2022 Financial Results and Highlights Operational Progress
03 Nov 2022 16:01:02 By Nasdaq GlobeNewswire
-
03 Nov 2022 09:00:03 By Nasdaq GlobeNewswire
-
Fate Therapeutics to Webcast Conference Call Reporting Third Quarter 2022 Financial Results
24 Oct 2022 16:01:00 By Nasdaq GlobeNewswire
-
05 Oct 2022 08:00:01 By Nasdaq GlobeNewswire
-
Fate Therapeutics to Participate at Upcoming September Investor Conferences
02 Sep 2022 08:00:00 By Nasdaq GlobeNewswire
-
09 Aug 2022 08:00:02 By Nasdaq GlobeNewswire
-
Fate Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Operational Progress
03 Aug 2022 16:01:00 By Nasdaq GlobeNewswire
-
Fate Therapeutics to Webcast Conference Call Reporting Second Quarter 2022 Financial Results
25 Jul 2022 16:01:00 By Nasdaq GlobeNewswire
-
Fate Therapeutics Appoints Brian T. Powl as Chief Commercial Officer
30 Jun 2022 16:01:00 By Nasdaq GlobeNewswire
-
28 Jun 2022 07:00:00 By Nasdaq GlobeNewswire
-
Fate Therapeutics to Present at the 2022 Jefferies Global Healthcare Conference
03 Jun 2022 08:00:00 By Nasdaq GlobeNewswire
-
Fate Therapeutics to Present at Upcoming May Investor Conferences
06 May 2022 16:01:00 By Nasdaq GlobeNewswire
-
Fate Therapeutics Reports First Quarter 2022 Financial Results and Highlights Operational Progress
04 May 2022 16:01:01 By Nasdaq GlobeNewswire
-
Fate Therapeutics to Webcast Conference Call Reporting First Quarter 2022 Financial Results
22 Apr 2022 08:00:00 By Nasdaq GlobeNewswire